Diligence memo · auto-generated · as of July 2, 2026
Epic Research & Diagnostics Inc
Epic Research & Diagnostics Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Epic Research & Diagnostics Inc operates in Biotechnology, based in Scottsdale.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Epic Research & Diagnostics Inc has raised $3.2M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.9M on 2008-12-11.
Most recent recorded round closed around 2008-12-11.
Valuation (modeled)modeled
Provath models Epic Research & Diagnostics Inc at approximately $85M (range $1.4M–$667M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.82× the median modeled value of Seed Biotechnology companies in 2007–2009 (47 peers) — value vs value, same stage and era. Within the normal band (82% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 17.6 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 35% of Biotechnology peers (4293 compared).
Modeled value ranks above 55% of those peers.
Closest niche peers: Bioassets Development Corp, Aubrey Inc, EndoMetabolic Solutions, Inc., Targegen Inc, Promethean Surgical Devices, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.